Efficacy of 5-hydroxytryptamine 3 receptor antagonists versus metoclopramide for preventing nausea and vomiting during azacitidine chemotherapy in patients with myelodysplastic syndromes or acute leukemia: a retrospective observational study
Abstract Background 5-Hydroxytryptamine 3 receptor antagonists (5-HT3RAs) and dexamethasone are recommended to prevent azacitidine-induced nausea and vomiting. In clinical practice, 5-HT3RAs or metoclopramide is often used without dexamethasone. In this study, we aimed to determine whether 5-HT3RAs...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2025-04-01
|
| Серии: | Journal of Pharmaceutical Health Care and Sciences |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s40780-025-00444-3 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|